{
  "version": "1.2.0",
  "chapters": [
    {
      "title": "Welcome to Oxford+",
      "startTime": 0,
      "endTime": 8
    },
    {
      "title": "Meet Camilla Easter: From Vet to CEO",
      "startTime": 8,
      "endTime": 82
    },
    {
      "title": "The Obesity Epidemic and OMP's Unique Approach",
      "startTime": 82,
      "endTime": 132
    },
    {
      "title": "Introducing Sirona: A Revolutionary Obesity Treatment",
      "startTime": 132,
      "endTime": 291
    },
    {
      "title": "Challenges and Innovations in Obesity Treatment",
      "startTime": 291,
      "endTime": 413
    },
    {
      "title": "Funding and Investor Relations",
      "startTime": 413,
      "endTime": 443
    },
    {
      "title": "Navigating the Current Economic Climate",
      "startTime": 443,
      "endTime": 514
    },
    {
      "title": "Clinical Trials and Regulatory Approvals",
      "startTime": 514,
      "endTime": 644
    },
    {
      "title": "The Global Impact and Future of Sirona",
      "startTime": 644,
      "endTime": 1106.02
    },
    {
      "title": "The Oxford Ecosystem and Expansion",
      "startTime": 1106.02,
      "endTime": 1733.02
    },
    {
      "title": "Future Trials and Launch",
      "startTime": 1733.02,
      "endTime": 2010.02
    }
  ]
}